Danni Brogden attended the IANS meeting in New York in June 2022. As well as enjoying the New York city life, she presented the study teams’ work on the treatment of early ASCC.
The results from the ANCHOR study have been published. This is the first randomised control trial to finally determine the benefit of treating anal HSIL in the prevention of anal squamous cell carcinoma in PLWH. The study showed a 57% … Continued